Department of Pharmacology and Physiology, UMDNJ-New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07101-1709, USA.
Cardiovasc Res. 2010 Jul 15;87(2):254-61. doi: 10.1093/cvr/cvq139. Epub 2010 May 11.
The nitric oxide (NO) cascade and endothelial NO synthase (eNOS) are best known for their role in endothelium-mediated relaxation of vascular smooth muscle. Activation of eNOS by certain inflammatory stimuli and enhanced NO release have also been shown to promote increased microvascular permeability. However, it is not entirely clear why activation of eNOS by certain vasodilatory agents, like acetylcholine, does not affect microvascular permeability, whereas activation of eNOS by other inflammatory agents that increase permeability, like platelet-activating factor, does not cause vasodilation. In this review, we discuss the evidence demonstrating the role of eNOS in the elevation of microvascular permeability. We also examine the relative importance of eNOS phosphorylation and localization in its function to promote elevated microvascular permeability as well as emerging topics with regard to eNOS and microvascular permeability regulation.
一氧化氮(NO)级联和内皮型一氧化氮合酶(eNOS)以其在血管内皮介导的血管平滑肌松弛中的作用而闻名。某些炎症刺激物激活 eNOS 和增强 NO 释放也被证明可以促进微血管通透性增加。然而,目前尚不完全清楚为什么某些血管扩张剂(如乙酰胆碱)激活 eNOS 不会影响微血管通透性,而其他增加通透性的炎症介质(如血小板激活因子)激活 eNOS 却不会引起血管扩张。在这篇综述中,我们讨论了证明 eNOS 在增加微血管通透性中的作用的证据。我们还检查了 eNOS 磷酸化和定位在促进升高的微血管通透性中的相对重要性,以及与 eNOS 和微血管通透性调节有关的新兴主题。